Working… Menu

The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03577132
Recruitment Status : Not yet recruiting
First Posted : July 5, 2018
Last Update Posted : July 31, 2018
Information provided by (Responsible Party):
Ja Hyeon Ku, Seoul National University Hospital

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : May 31, 2020
Estimated Study Completion Date : May 31, 2022

Publications automatically indexed to this study by Identifier (NCT Number):